Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial-Reference-Cited by-同舟云学术

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial

Published:2017-08 Issue:8 Volume:18 Page:1116-1125
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Faivre-Finn Corinne,Snee Michael,Ashcroft Linda,Appel Wiebke,Barlesi Fabrice,Bhatnagar Adityanarayan,Bezjak Andrea,Cardenal Felipe,Fournel Pierre,Harden Susan,Le Pechoux Cecile,McMenemin Rhona,Mohammed Nazia,O'Brien Mary,Pantarotto Jason,Surmont Veerle,Van Meerbeeck Jan P,Woll Penella J,Lorigan Paul,Blackhall Fiona

Publisher

Elsevier BV

Subject

Oncology

Reference21 articles.

1. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database;Govindan;J Clin Oncol,2006

2. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group;Murray;J Clin Oncol,1993

3. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine;Johnson;J Clin Oncol,1996

4. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide;Turrisi;N Engl J Med,1999

5. A meta-analysis of thoracic radiotherapy for small-cell lung cancer;Pignon;N Engl J Med,1992

Cited by 436 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers;International Journal of Radiation Oncology*Biology*Physics;2024-10

2. Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-10

3. Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer;New England Journal of Medicine;2024-09-13

4. Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer;Cancer Research Communications;2024-09-01

5. Effect of FDG PET-CT for Staging and Radiotherapy Planning – A Comparison of Cohorts From Two Randomized Trials of Thoracic Radiotherapy in Limited-Stage SCLC;JTO Clinical and Research Reports;2024-09